Insulin pens: The modern delivery devices

Journal of Association of Physicians of India

Volumn 59, Issue SUPPL APRIL2011, 2011, Pages 38-40

  Baruah, Manash P ^a  

^a Excel Care Hospitals ^*  (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ARTICLE; DIABETES MELLITUS; DISPOSABLE EQUIPMENT; DRUG DELIVERY SYSTEM; DRUG SELF ADMINISTRATION; FEMALE; HUMAN; INSTRUMENTATION; PATIENT COMPLIANCE; PATIENT SATISFACTION; PREGNANCY; QUALITY OF LIFE; SUBCUTANEOUS DRUG ADMINISTRATION; SYRINGE;

DIABETES MELLITUS; DISPOSABLE EQUIPMENT; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; PATIENT COMPLIANCE; PATIENT SATISFACTION; PREGNANCY; QUALITY OF LIFE; SELF ADMINISTRATION; SYRINGES;

EID: 80051573835     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Stratton IM, Adler AI, Neil AW, Matthews DR, Manley SE, Cull CA, Hadden D, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 2000;321:405-412
2. Coscelli C, Lostiab S, Lunettac M, Nosarid I, Coronele GA. Safety, efficacy, acceptability of a pre-filled insulin pen in diabetic patients over 60 years old. Diabetes Res Clin Pract 1995;28:173-177
3. Bohannon NJV, Jack DB. Type II diabetes: Tips for managing your older patients. Geriatrics 1996;51:28-35
4. Marcus A. Diabetes care - insulin delivery in a changing world. Medscape J Med 2008;10:120
5. Le Floch JP, Herbreteau C, Lange F, Perlemuter L. Biologic material in needles and cartridges after insulin injection with a pen in diabetic patients. Diabetes Care 1998;21:1502-1504
6. Rubin RR, Peyrot M. Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies. Diabetes Care 2004;27:2495-2497
7. Keith K, Nicholson D, Rogers D. Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump. Clin Pediatr (Phila) 2004;43:69-74
8. Weise A, Pfützner JW, Borig J, Pfützner AM, Safinowski M, Hänel H, Musholt PB, et al. Comparison of the dose accuracy of prefilled insulin pens. J Diabetes Sci Technol 2009;3:149-153
9. Rissler J, Jørgensen C, Hansen RM, Hansen NA. Evaluation of the injection force dynamics of a modified prefilled insulin pen. Expert Opin Pharmacother 2008;9:2217-2222
10. Pfützner A, Reimer T, Hohberg C, Frøkjær LPF, Jørgensen C. Prefilled insulin device with reduced injection force: patient perception and accuracy. Curr Med Res Opin 2008;24: 2545-2549
11. efferson IG, Marteau TM, Smith MA, Baum JD. A multiple injection regimen using an insulin injection pen and pre-filled cartridged soluble human insulin in adolescents with diabetes. Diabet Med 1985;2:493-497
12. Korytkowski M, Bell D, Jacobsen C, Suwannasari R. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clin Ther 2003;25:2836-2848
13. Lteif AN, Schwenk WF. Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes. Diabetes Care 1999;22:137-140
14. Asakura T, Seino H. Insulin dosing accuracy with FlexPen® versus syringe by healthcare professionals and healthy volunteers. Diabetes 2005;54(Suppl. 1):A498-A499.
15. Lee WC, Balu S, Cobden D, Joshi AV, Pashos CL. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clin Ther 2006;28:1712-1725
16. Ignaut DA, Opincar M, Lenox S. FlexPen® and KwikPen™ prefilled insulin devices: A laboratory evaluation of ergonomic and injection force characteristics. J Diabetes Sci Technol 2008;2:533-537
17. Rex J, Jensen KH, Lawton SA. A review of 20 years' experience with the Novopen family of insulin injection devices. Clin Drug Invest 2006;26:367-401
18. Lawton B, Berg B. Comparative evaluation of FlexPen, a new prefilled insulin delivery system, among patients and healthcare professional. Diabetes 2001;50:A440
19. Niskanen L, Jensen LE, Råstam J, Nygaard-Pedersen L, Erichsen K, Vora JP. Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus. Clin Ther 2004;26:531-540
20. Hänel H, Weise A, Sun W, Pfützner JW, Thomé N, Pfützner A. Differences in the dose accuracy of insulin pens. J Diabetes Sci Tech 2008;2:478-481
21. Asakura T, Seino H, Kageyama M, Yohkoh N. Evaluation of injection force of three insulin delivery pens. Expert Opin Pharmacother 2009;10:1389-1393.